Use of imatinib mesylate in a 15-month old with Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia. [electronic resource]
- Pediatric blood & cancer Jan 2008
- 186 p. digital
Publication Type: Case Reports; Letter
1545-5017
10.1002/pbc.21217 doi
Antineoplastic Agents--therapeutic use Benzamides Enzyme Inhibitors--therapeutic use Female Humans Imatinib Mesylate Infant Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Piperazines--therapeutic use Protein-Tyrosine Kinases--antagonists & inhibitors Pyrimidines--therapeutic use